Member Info for ojls

Nice little profit made on the disposal of a fairly small number of shares in Northcoders (4.9% retained).

Rome wasn't built in a day. It takes time to build a decent portfolio of investments and unfortunately even the very best investors get it wrong on occasion. I am guessing its mainly the short termers (holding 12 months or less) that want to boot the BoD because they haven't made money overnight.
I am more annoyed at the boards lack of comms on occasion but that doesn't mean they need voting off, rather telling off and asking they do better in the future.

I think PET mentioned something along the lines of "completion in the first quarter of 2022" in one of their news releases late last year so you would think we are close to completion (why drag it out if not?)

So close, yet so far. Another extension!

That's the last trading day of the year done with and we don't appear to have an exclusivity extension. Could we be in for some good news next week. Fingers crossed.
Good luck to all and happy new year

Currently holding a fairly decent chunk and averaging down every now and again.
I think half the problem with VELA is retail investors got really excited about SGS and forgot about every other investment thinking that money was going to be made in days/weeks.
Reality is: investments take a little time. If you can afford to hold then hold as another few months from now the SP will be in a very different place (and I'm not talking about the consolidation :) )
New year, new opportunities, new share price. Fingers crossed.

There is mention of utilizing funds for follow on investments so it's entirely possible. I still wonder whether the BoD will throw a load of cash into AZD1656 for phase three trials (as a standalone covid treatment) once it has been commercialized to treat diabetic patients.

I'm not really sure what the board are playing at. No such thing as a consolidation that improves the real life value to shareholders. Hopefully SGS pull their finger out ahead of the AGM so the team at VELA have something positive to talk about.

VELA receives 8% of the proceeds of the sale/licensing of AZD1656 (Excluding the first £19.2 million)
Original RNS: https://www.lse.co.uk/rns/VELA/investment-in-potential-covid-treatment-placing-7d8tgl50wf3qrkm.html

In the event that AZD is sold for £100m
- £19.2m = £80.8m
8% of £80.8m = £6.464m due to VELA

Many investors are expecting the sale/licensing deal will be worth significantly more (Potentially over £200m)
In short, the right deal could double/triple/quadruple the value of the company.

Its all retail buyers/traders dealing in small amounts so the SP isn't going to do much. There was some decent size buying/accumulation last week. Those that believe AZD1656 is a success will no doubt have already taken their positions ahead of news.
Annoyingly I think the limited information shared about the trial success has a lot to do with AstraZeneca wanting to keep a lid on everything until contracts are signed. This really doesn't help investors in the short term but it certainly will come the big day when an RNS lands (hopefully very soon).
Hold for Gold

If so, please could we have another 60%+. It would be nice to see my average before Xmas :)

I don't think it would be considered a closed period as the companies and their directors are not considered insiders given everything is being handled by SGS (VELS/Mush et al are simply investors like you and I). Commercialisation news could be dropped by SGS at any time so I guess some directors are buying off the back of this weeks RNS confident that everyone is in for a pay day..

Anything under the 0.8-0.9 range is cheap. As mentioned on here yesterday the value of VELA is still at a level that suggests the SGS outcome is unknown despite the fact that is looks like a nailed on success.
Well done to those loading up at this level as it will look like a complete bargain in less than a handful of weeks.
I am slightly surprised we didn't see a 50%+ rise yesterday. Perhaps we will see a more gradual rise as the dust settles and the media start promoting the success of the trials.

That's right, a company with an 8% share in a covid beating tablet that could save thousands of lives is currently valued at £9m.
Talk about an investment opportunity. Mega entry point for new investors (And yes I am incredibly jealous of those picking up shares at bargain basement levels as my average is significantly higher )

Sub 0.8 we are essentially valued on the basis that the SGS trial outcome is unknown.
We know AZD1656 is both safe and effective in treating covid patients with diabetes and commercial talks are underway. I wouldn't be surprised to see the SP head back to the 0.8 - 0.9 range on todays RNS as it basically indicates that everything is going according to plan. We just need commercialisation news and potentially an indication of further trials as a standalone covid treatment that could be worth a huge sum of money.

Congratulations to those that bought the dip while the impatient and nervous left to chase rainbows. AZD1656 is looking very good and the VELA board must be well aware that a commercial deal is not far away.

No such luck. LSE is playing up. Last trade was a sell at 0.047.
Its officially bargain basement time again :)

I am intrigued?! VELA managed to acquire 8% with an investment of £2.5m (ish).
On that valuation a controlling stake @ 51% would come in at circa £15,937,500. I'm pretty sure that this amount would be too low given the progression made since the first investment (AZD1656 is worth a lot more given completion of phase 2 trials) and more to the point where have the bod managed to get another £13.5m from :)

I don't suppose you can offer up any more information regarding this email?
The phrase "the silence is far from deliberate" may suggest to some that someone/somewhere is dragging their feet? (resulting in VELA being unable to offer up any information)
Either way, its nice to hear the Brent has responded to an email.
Come on VELA, give us the SGS news and put the SP back to where it belongs!

Baffling to see selling continue at this level (no one is making anything). Although I agree that the news flow has been limited, there appears to be a complete lack of patience from holders who are not willing to wait more than a month or two.